RESTORE Act
The source supplies the latest action, but no lifecycle stage.
Latest action (13 Jun 2024): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
What this bill does
The RESTORE Act would direct federal health agencies to expand research, data collection, and training related to reproductive health conditions such as endometriosis, adenomyosis, polycystic ovary syndrome, uterine fibroids, and blocked fallopian tubes, as well as "restorative reproductive medicine" and fertility awareness-based methods. It requires the Department of Health and Human Services and the CDC to produce periodic reports on the standard of care for infertility diagnosis, on access to restorative reproductive medicine, and on whether the National Survey of Family Growth should include related questions. It also amends Title X of the Public Health Service Act to make providers of restorative reproductive medicine eligible for Title X grants, requires Title X grantee staff to receive related training, and directs an expansion of Teen Pregnancy Prevention program grants to entities specializing in these approaches. Separately, it bars the federal government and recipients of federal funding from penalizing health care providers who decline to participate in assisted reproductive technology (such as IVF) based on religious or moral objections.
The bill would primarily affect federal health agencies (HHS, CDC, NIH, AHRQ), Title X family planning grantees, medical training programs, and health care providers who choose not to participate in assisted reproductive technology. It could also affect patients seeking infertility or reproductive health diagnoses, by potentially expanding research, data, and provider training in this area, and by protecting providers with religious or moral objections to assisted reproductive technology from being penalized by federally funded entities.
The bill was introduced in the Senate on June 13, 2024, by Senator Cindy Hyde-Smith with several cosponsors, and referred to the Senate Committee on Health, Education, Labor, and Pensions. It has not received a committee vote or floor action. As with most introduced bills, it would need to pass through committee, both chambers of Congress, and be signed by the President to become law; there is no indication in the provided material that further action has occurred.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Timeline
13 Jun 2024
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Common questions
- What does S. 4533 do?
- The RESTORE Act would direct federal health agencies to expand research, data collection, and training related to reproductive health conditions such as endometriosis, adenomyosis, polycystic ovary syndrome, uterine fibroids, and blocked fallopian tubes, as well as "restorative reproductive medicine" and fertility awareness-based methods. It requires the Department of Health and Human Services and the CDC to produce periodic reports on the standard of care for infertility diagnosis, on access to restorative reproductive medicine, and on whether the National Survey of Family Growth should include related questions. It also amends Title X of the Public Health Service Act to make providers of restorative reproductive medicine eligible for Title X grants, requires Title X grantee staff to receive related training, and directs an expansion of Teen Pregnancy Prevention program grants to entities specializing in these approaches. Separately, it bars the federal government and recipients of federal funding from penalizing health care providers who decline to participate in assisted reproductive technology (such as IVF) based on religious or moral objections. The bill would primarily affect federal health agencies (HHS, CDC, NIH, AHRQ), Title X family planning grantees, medical training programs, and health care providers who choose not to participate in assisted reproductive technology. It could also affect patients seeking infertility or reproductive health diagnoses, by potentially expanding research, data, and provider training in this area, and by protecting providers with religious or moral objections to assisted reproductive technology from being penalized by federally funded entities. The bill was introduced in the Senate on June 13, 2024, by Senator Cindy Hyde-Smith with several cosponsors, and referred to the Senate Committee on Health, Education, Labor, and Pensions. It has not received a committee vote or floor action. As with most introduced bills, it would need to pass through committee, both chambers of Congress, and be signed by the President to become law; there is no indication in the provided material that further action has occurred.
- Has S. 4533 become law?
- The source does not supply a confirmed lifecycle stage for S. 4533. Check the latest action and official source below.
- Who sponsored S. 4533?
- S. 4533 was sponsored by Sen. Hyde-Smith, Cindy [R-MS] (R-MS), with 6 cosponsors.
- What's the latest action on S. 4533?
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (13 Jun 2024).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Access to Medical Supplies Act
Lower Premiums, Faster Payments Act
More bills from Sen. Hyde-Smith, Cindy [R-MS]
Ecuador Shrimp Tariff Act
A resolution designating the week of September 20 through September 27, 2026, as "Gold Star Families Remembrance Week".
Rural Mothers and Fathers Choice Act
Federal Tax Credit Scholarship Improvement Act
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.